Using Neurofibromatosis-1 to Better Understand and Treat Pediatric Low-Grade Glioma
- 1 October 2008
- journal article
- other
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 23 (10) , 1186-1194
Abstract
Relatively little is known about the seminal genetic events that trigger the development of low-grade gliomas in children. Genetically engineered mouse models of the neurofibromatosis-1—inherited tumor predisposition syndrome have identified key intracellular growth control pathways, defined the contribution of the tumor microenvironment to glioma growth, and helped researchers understand the genetic basis for glioma susceptibility. In addition, genetically engineered mouse low-grade glioma models have recently been used in preclinical therapeutic studies to evaluate the efficacy of particular biologically based therapies and to define outcome measures.Keywords
This publication has 74 references indexed in Scilit:
- Gliomas in Neurofibromatosis Type 1: A Clinicopathologic Study of 100 PatientsJournal of Neuropathology & Experimental Neurology, 2008
- The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cellsLeukemia Research, 2007
- Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivoNeuroImage, 2007
- Anticancer Therapies Combining Antiangiogenic and Tumor Cell Cytotoxic Effects Reduce the Tumor Stem-Like Cell Fraction in Glioma Xenograft TumorsCancer Research, 2007
- TSC1 Sets the Rate of Ribosome Export and Protein Synthesis through Nucleophosmin TranslationCancer Research, 2007
- Development of Farnesyltransferase Inhibitors for Clinical Cancer Therapy: Focus on Hematologic MalignanciesCancer Investigation, 2007
- Nucleophosmin Is Essential for Ribosomal Protein L5 Nuclear ExportMolecular and Cellular Biology, 2006
- Harnessing preclinical mouse models to inform human clinical cancer trialsJournal of Clinical Investigation, 2006
- Cerebrospinal Fluid Proteomic Analysis Reveals Dysregulation of Methionine Aminopeptidase-2 Expression in Human and Mouse Neurofibromatosis 1–Associated GliomaCancer Research, 2005
- Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal studyThe Journal of Pediatrics, 1994